These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27029063)

  • 81. The current understanding of the immune landscape relative to radiotherapy across tumor types.
    Iliadi C; Verset L; Bouchart C; Martinive P; Van Gestel D; Krayem M
    Front Immunol; 2023; 14():1148692. PubMed ID: 37006319
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Systemic Inflammation Score is Associated with the Survival of Patients with Prostate Cancer.
    Xie J; Xiao X; Dong Z; Wang Q
    J Inflamm Res; 2023; 16():963-975. PubMed ID: 36915616
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer.
    Hu W; Pei Y; Ning R; Li P; Zhang Z; Hong Z; Bao C; Guo X; Sun Y; Zhang Q
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4533-4545. PubMed ID: 36138265
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Modulation of Peripheral Immune Cell Subpopulations After RapidArc/Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: Findings and Comparison With 3D Conformal/Conventional Fractionation Treatment.
    D'Auria F; Statuto T; Rago L; Montagna A; Castaldo G; Schirò I; Zeccola A; Virgilio T; Bianchino G; Traficante A; Sgambato A; Fusco V; Valvano L; Calice G
    Front Oncol; 2022; 12():829812. PubMed ID: 35719968
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research.
    Chen X; Yu Q; Li P; Fu S
    Front Oncol; 2021; 11():760752. PubMed ID: 34804961
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients.
    Bosas P; Zaleskis G; Dabkevičiene D; Dobrovolskiene N; Mlynska A; Tikuišis R; Ulys A; Pašukoniene V; Jarmalaitė S; Jankevičius F
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442004
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis.
    Wang Q; Li S; Qiao S; Zheng Z; Duan X; Zhu X
    Front Immunol; 2021; 12():648652. PubMed ID: 34220806
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hadrontherapy Interactions in Molecular and Cellular Biology.
    Thariat J; Valable S; Laurent C; Haghdoost S; Pérès EA; Bernaudin M; Sichel F; Lesueur P; Césaire M; Petit E; Ferré AE; Saintigny Y; Skog S; Tudor M; Gérard M; Thureau S; Habrand JL; Balosso J; Chevalier F
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878191
    [TBL] [Abstract][Full Text] [Related]  

  • 89. T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation.
    Cerqueira MA; Ferrari KL; de Mattos AC; Monti CR; Reis LO
    World J Urol; 2020 Mar; 38(3):673-680. PubMed ID: 31263944
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Assessing the interactions between radiotherapy and antitumour immunity.
    Grassberger C; Ellsworth SG; Wilks MQ; Keane FK; Loeffler JS
    Nat Rev Clin Oncol; 2019 Dec; 16(12):729-745. PubMed ID: 31243334
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
    Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
    J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study.
    Sanguineti G; Giannarelli D; Petrongari MG; Arcangeli S; Sangiovanni A; Saracino B; Farneti A; Faiella A; Conte M; Arcangeli G
    Radiat Oncol; 2019 Jan; 14(1):23. PubMed ID: 30700317
    [TBL] [Abstract][Full Text] [Related]  

  • 93. TGF-beta 1 levels are associated with lymphocyte percentages in patients with lung cancer treated with radiation therapy.
    Luo J; Hu S; Wei T; Sun J; Liu N; Wang J
    Onco Targets Ther; 2018; 11():8349-8355. PubMed ID: 30568457
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Impact of curative radiotherapy on the immune status of patients with localized prostate cancer.
    Eckert F; Schaedle P; Zips D; Schmid-Horch B; Rammensee HG; Gani C; Gouttefangeas C
    Oncoimmunology; 2018; 7(11):e1496881. PubMed ID: 30393582
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors.
    Ellsworth SG
    Adv Radiat Oncol; 2018; 3(4):512-519. PubMed ID: 30370350
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients.
    Yuan C; Wang Q
    Clin Transl Oncol; 2018 Sep; 20(9):1219-1225. PubMed ID: 29536332
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma.
    Liu J; Zhao Q; Deng W; Lu J; Xu X; Wang R; Li X; Yue J
    Radiat Oncol; 2017 May; 12(1):90. PubMed ID: 28558844
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes.
    Yang ZR; Zhao N; Meng J; Shi ZL; Li BX; Wu XW; Li P; Zhang Q; Wei XB; Fu S
    Oncotarget; 2016 May; 7(18):26422-35. PubMed ID: 27029063
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.
    Okada T; Tsuji H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Tsujii H;
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):968-72. PubMed ID: 22898380
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.